3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione has been researched along with Cancer of the Uterus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blessing, JA; Homesley, HD; Petty, W; Thigpen, JT | 1 |
| Blessing, JA; Curry, SL; Hacker, N; Homesley, HD; Thigpen, JT | 1 |
2 other study(ies) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Cancer of the Uterus
| Article | Year |
|---|---|
Phase II trial of piperazinedione in the treatment of advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group Study.
Topics: Adult; Aged; Carcinoma; Drug Evaluation; Female; Humans; Middle Aged; Piperazines; Uterine Neoplasms | 1986 |
Phase II trial of piperazinedione in patients with advanced or recurrent uterine sarcoma. A Gynecologic Oncology Group study.
Topics: Adult; Aged; Drug Evaluation; Female; Humans; Leukopenia; Middle Aged; Piperazines; Sarcoma; Thrombocytopenia; Uterine Neoplasms | 1985 |